(Mark One) | |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
(Zip Code) | ||||||
(Address of principal executive office (US)) | ||||||
(Registrant's telephone number, including area code) | ||||||
Securities registered pursuant to Section 12(b) of the Act | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
☑ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Page | ||
Item 1. | ||
Item 1A. | ||
Item 1B. | ||
Item 1C. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
Item 7. | ||
Item 7A. | ||
Item 8. | ||
Item 9. | ||
Item 9A. | ||
Item 9B. | ||
Item 9C. | ||
Item 10. | ||
Item 11. | ||
Item 12. | ||
Item 13. | ||
Item 14. | ||
Item 15. | ||
Item 16. | ||

Name | Age | Title | ||
Ingrid Joerg | 56 | Chief Executive Officer (1)(2) | ||
Jack Guo | 47 | Executive Vice President & Chief Financial Officer | ||
Philippe Hoffmann | 60 | President, A&T business unit | ||
Matthew Perkins | 58 | President, P&ARP business unit | ||
Stephane Corre | 53 | President, AS&I business unit | ||
Ludovic Piquier | 52 | Senior Vice President Manufacturing Excellence and Chief Technical Officer | ||
Philip Ryan Jurkovic | 54 | Senior Vice President & Chief Human Resources Officer | ||
Nicolas Brun | 59 | Senior Vice President, Public Affairs, Communications and Sustainability | ||
Marcus Becker | 50 | Senior Vice President & Chief Procurement Officer | ||
Niklaus Schild | 47 | Senior Vice President, Chief Information Officer and Chief Digital Officer | ||
Stephen Walters | 61 | Senior Vice President, Group General Counsel, Board Secretary |
Location | Country | Owned/Leased | ||
Aerospace & Transportation | ||||
Issoire | France | Owned | ||
Montreuil-Juigné | France | Owned | ||
Steg (1) | Switzerland | Owned | ||
Sierre | Switzerland | Owned | ||
Ravenswood, WV | United States | Owned | ||
Packaging & Automotive Rolled Products | ||||
Biesheim, Neuf-Brisach | France | Owned | ||
Singen | Germany | Owned | ||
Muscle Shoals, AL | United States | Owned | ||
Bowling Green, KY | United States | Owned | ||
Automotive Structures & Industry | ||||
Lakeshore, Ontario (JV) (2) | Canada | Leased | ||
Changchun, Jilin Province (JV) (3) | China | Leased | ||
Děčín | Czech Republic | Owned(4) | ||
Nuits-Saint-Georges | France | Owned | ||
Neckarsulm | Germany | Owned | ||
Gottmadingen | Germany | Leased | ||
Singen | Germany | Owned(4) | ||
San Luis Potosi | Mexico | Leased | ||
Levice | Slovakia | Owned/Leased | ||
Zilina | Slovakia | Leased | ||
Vigo | Spain | Leased | ||
Chippis | Switzerland | Owned | ||
Sierre | Switzerland | Owned | ||
Van Buren, MI | United States | Leased | ||
White, GA | United States | Leased |

Company/Index | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Constellium | $100 | $128 | $85 | $143 | $73 | $135 |
Russell 2000 Index | 100 | 115 | 91 | 107 | 119 | 134 |
S&P SmallCap 600 Materials Index | 100 | 118 | 111 | 133 | 135 | 154 |
Period | Total number of shares purchased | Average price paid per share (in U.S. dollars) | Total number of shares purchased as part of publicly announced plans or programs | Maximum approximate dollar value of shares that may yet be purchased under the program | ||||
October 1 - October 31, 2025 | 650,000 | 16.18 | 650,000 | 135,698,617 | ||||
November 1 - November 30, 2025 | 550,000 | 16.01 | 550,000 | 126,892,101 | ||||
December 1 - December 31, 2025 | 1,177,077 | 17.65 | 1,177,077 | 106,121,002 | ||||
Total | 2,377,077 | 2,377,077 | 106,121,002 |
Year ended December 31, 2025 | ||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | ||
A&T | 23% | 47% | ||
P&ARP | 60% | 49% | ||
AS&I | 19% | 10% | ||
H&C (1) | —% | (6)% | ||
Total | 100% | 100% | ||
Year ended December 31, | Percent changes | |||||
(U.S. dollars per ton) | 2025 | 2024 | 2025 vs 2024 | |||
Average LME transaction price | 2,632 | 2,419 | 9% | |||
Average Midwest premium | 1,298 | 432 | 200% | |||
Average all-in aluminum price U.S. | 3,930 | 2,851 | 38% | |||
Average LME transaction price | 2,632 | 2,419 | 9% | |||
Average Rotterdam premium | 252 | 314 | (20)% | |||
Average all-in aluminum price Europe | 2,884 | 2,733 | 6% | |||
For the years ended December 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2025 | 2024 | ||||||
Revenue | 8,449 | 100% | 7,335 | 100% | ||||
Cost of sales (excluding depreciation and amortization) | (7,262) | 86% | (6,397) | 87% | ||||
Depreciation and amortization | (330) | 4% | (304) | 4% | ||||
Selling and administrative expenses | (332) | 4% | (313) | 4% | ||||
Research and development expenses | (51) | 1% | (49) | 1% | ||||
Other gains and losses – net | 43 | 1% | (26) | —% | ||||
Finance costs – net | (109) | 1% | (111) | 2% | ||||
Income before tax | 408 | 5% | 135 | 2% | ||||
Income tax expense | (133) | 2% | (75) | 1% | ||||
Net income | 275 | 3% | 60 | 1% | ||||
Shipment volumes (in kt) | 1,495 | n/a | 1,438 | n/a | ||||
For years ended December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Realized gains / (losses) on foreign currency derivatives - net | 11 | (10) | ||
Realized gains on commodities derivatives - net | 8 | 22 | ||
Realized gains on derivatives | 19 | 12 | ||
Unrealized gains / (losses) on foreign currency derivatives - net | 28 | (20) | ||
Unrealized gains on commodities derivatives - net | 28 | 19 | ||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net | 56 | (1) | ||
For years ended December 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2025 | 2024 | ||||||
A&T | 1,968 | 23% | 1,816 | 25% | ||||
P&ARP | 5,078 | 60% | 4,196 | 57% | ||||
AS&I | 1,579 | 19% | 1,432 | 20% | ||||
H&C (1) | 5 | —% | 6 | —% | ||||
Inter-segment eliminations | (181) | n.m | (115) | n.m | ||||
Total revenue | 8,449 | 100% | 7,335 | 100% | ||||
For years ended December 31, | ||||||||
(in kt and as a % of shipments) | 2025 | 2024 | ||||||
A&T | 207 | 14% | 209 | 15% | ||||
P&ARP | 1,086 | 73% | 1,027 | 71% | ||||
AS&I | 202 | 13% | 201 | 14% | ||||
Total shipments | 1,495 | 100% | 1,438 | 100% | ||||
For years ended December 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2025 | 2024 | ||||||
A&T | 339 | 17% | 292 | 16% | ||||
P&ARP | 353 | 7% | 242 | 6% | ||||
AS&I | 72 | 5% | 74 | 5% | ||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the year ended December 31, 2024 | 292 | 242 | 74 | |||
Volume | (1) | 48 | — | |||
Price and product mix | (35) | 20 | (6) | |||
Costs | 74 | 34 | 2 | |||
Foreign exchange and other | 9 | 9 | 2 | |||
Segment Adjusted EBITDA for the year ended December 31, 2025 | 339 | 353 | 72 |
For years ended December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Net Cash Flows from / (used in) | ||||
Operating activities | 489 | 301 | ||
Investing activities | (309) | (313) | ||
Financing activities | (215) | (61) | ||
Net (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes | (35) | (73) | ||
For years ended December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Net income | 275 | 60 | ||
Income tax expense | 133 | 75 | ||
Finance costs – net | 109 | 111 | ||
Expenses on factoring arrangements | 21 | 22 | ||
Depreciation and amortization | 330 | 304 | ||
Impairment of assets (A) | 21 | 24 | ||
Restructuring costs (B) | 3 | 11 | ||
Unrealized (gains) / losses on derivatives | (56) | 1 | ||
Unrealized exchange losses / (gains) from the remeasurement of monetary assets and liabilities – net | — | (1) | ||
Pension and other post-employment benefits - non - operating gains | (14) | (11) | ||
Share based compensation | 19 | 25 | ||
Losses on disposal | 4 | 4 | ||
Other (C) | 1 | (2) | ||
Adjusted EBITDA1 | 846 | 623 | ||
of which Metal price lag (D) | 126 | 48 | ||
(in millions of U.S. dollars) | Effect on income before tax | Effect on pretax equity | ||
Trade receivables | 6 | — | ||
Trade payables | (1) | — | ||
Derivatives on commercial transactions (A) | (43) | (32) | ||
Net commercial transaction exposure | (38) | (32) | ||
Cash in Bank and intercompany loans | 99 | — | ||
Borrowings | (131) | — | ||
Derivatives on financing transactions | 32 | — | ||
Net financing transaction exposure | — | — | ||
Total | (38) | (32) |
(in millions of U.S. dollars) | Effect on net income | Effect on equity | ||
10% strengthening U.S. dollar versus euro | (15) | (45) |
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
Revenue | 2 | |||||||
Cost of sales (excluding depreciation and amortization) | ( | ( | ( | |||||
Depreciation and amortization | ( | ( | ( | |||||
Selling and administrative expenses | ( | ( | ( | |||||
Research and development expenses | ( | ( | ( | |||||
Other gains and losses – net | 5 | ( | ( | |||||
Finance costs – net | 6 | ( | ( | ( | ||||
Income before tax | ||||||||
Income tax expense | 7 | ( | ( | ( | ||||
Net income | ||||||||
Attributable to: | ||||||||
Equity holders of Constellium | ||||||||
Non-controlling interests | ||||||||
Net income | ||||||||
Earnings per share attributable to the equity holders of Constellium (in dollars) | Notes | 2025 | 2024 | 2023 | ||||
Basic | 8 | |||||||
Diluted | 8 |
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
Net income | ||||||||
Other comprehensive income / (loss) | ||||||||
Net change in post-employment benefit obligations | ( | |||||||
Income tax on net change in post-employment benefit obligations | ( | ( | ||||||
Net change in cash flow hedges | 16 | ( | ||||||
Income tax on cash flow hedges | ( | ( | ||||||
Currency translation adjustments | ( | ( | ||||||
Other comprehensive income / (loss) | 19 | ( | ( | |||||
Total comprehensive income | ||||||||
Attributable to: | ||||||||
Equity holders of Constellium | ||||||||
Non-controlling interests | ||||||||
Total comprehensive income | ||||||||
At December 31, | ||||||
(in millions of U.S. dollars) except share data and as otherwise stated | Notes | 2025 | 2024 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | ||||||
Trade receivables and other, net | 9 | |||||
Inventories | 10 | |||||
Fair value of derivatives instruments and other financial assets | 16 | |||||
Total current assets | ||||||
Non-current assets | ||||||
Property, plant and equipment, net | 11 | |||||
Goodwill | 13 | |||||
Intangible assets, net | 13 | |||||
Deferred tax assets | 7 | |||||
Trade receivables and other, net | ||||||
Fair value of derivatives instruments | 16 | |||||
Total non-current assets | ||||||
Total assets | ||||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 14 | |||||
Current portion of long-term debt | 15 | |||||
Fair value of derivatives instruments | 16 | |||||
Income tax payable | ||||||
Pension and other benefit obligations | 17 | |||||
Provisions | 18 | |||||
Total current liabilities | ||||||
Non-current liabilities | ||||||
Trade payables and other | ||||||
Long-term debt | 15 | |||||
Fair value of derivatives instruments | 16 | |||||
Pension and other benefit obligations | 17 | |||||
Provisions | 18 | |||||
Deferred tax liabilities | 7 | |||||
Total non-current liabilities | ||||||
Total liabilities | ||||||
Commitments and contingencies | 20 | |||||
Shareholder's equity | ||||||
Ordinary shares, par value € | ||||||
Additional paid in capital | ||||||
Accumulated other comprehensive income | 19 | ( | ||||
Retained earnings | ||||||
Treasury shares | ( | ( | ||||
Equity attributable to equity holders of Constellium | ||||||
Non-controlling interests | ||||||
Total equity | ||||||
Total equity and liabilities | ||||||
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2025 | ( | ( | ||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive income / (loss) | — | — | — | — | — | |||||||||||
Total comprehensive income / (loss) | — | — | — | — | ||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Other | — | — | — | — | — | — | ||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At December 31, 2025 | ( |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2024 | ||||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive income / (loss) | — | — | — | ( | — | — | ( | ( | ||||||||
Total comprehensive income / (loss) | — | — | — | ( | — | |||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Transactions with non-controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At December 31, 2024 | ( | ( |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive (loss) / income | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2023 | ( | |||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive income / (loss) | — | — | — | ( | — | — | — | ( | ||||||||
Total comprehensive income / (loss) | — | — | — | ( | — | |||||||||||
Share issuance | — | — | — | — | — | — | ||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Transactions with non-controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At December 31, 2023 | ||||||||||||||||
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
Net income | ||||||||
Adjustments | ||||||||
Depreciation and amortization | 11, 13 | |||||||
Impairment of assets | 5 | |||||||
Pension and other long-term benefits | 17 | |||||||
Finance costs - net | 6 | |||||||
Income tax expense | 7 | |||||||
Unrealized (gains) / losses on derivatives - net and from remeasurement of monetary assets and liabilities - net | ( | |||||||
Losses / (gains) on disposal | 5 | ( | ||||||
Other - net | ||||||||
Changes in working capital | ||||||||
Inventories | ( | ( | ||||||
Trade receivables | ( | ( | ( | |||||
Trade payables | ( | ( | ||||||
Other | ( | ( | ||||||
Change in provisions | ( | |||||||
Pension and other long-term benefits paid | 17 | ( | ( | ( | ||||
Interest paid | ( | ( | ( | |||||
Income tax paid | 7 | ( | ( | ( | ||||
Net cash flows from operating activities | ||||||||
Purchases of property, plant and equipment | 3 | ( | ( | ( | ||||
Property, plant and equipment inflows | 3 | |||||||
Collection of deferred purchase price receivable | 9 | |||||||
Acquisition of subsidiaries net of cash acquired | 22 | |||||||
Proceeds from disposals, net of cash | ( | |||||||
Other investing activities | ||||||||
Net cash flows used in investing activities | ( | ( | ( | |||||
Repurchase of ordinary shares | ( | ( | ||||||
Proceeds from issuance of long-term debt | ||||||||
Repayments of long-term debt | ( | ( | ( | |||||
Net change in revolving credit facilities and short-term debt | ( | ( | ||||||
Finance lease repayments | ( | ( | ( | |||||
Payment of financing costs and redemption fees | ( | |||||||
Transactions with non-controlling interests | ( | ( | ( | |||||
Other financing activities | ( | ( | ||||||
Net cash flows used in financing activities | ( | ( | ( | |||||
Net decrease in cash and cash equivalents | ( | ( | ||||||
Cash and cash equivalents - beginning of year | ||||||||
Net decrease in cash and cash equivalents | ( | ( | ||||||
Transfer of cash and cash equivalents from / (to) assets classified as held for sale | ||||||||
Effect of exchange rate changes on cash and cash equivalents | ( | |||||||
Cash and cash equivalents - end of year | ||||||||
Year ended December 31, 2024 | ||||||
(in millions of U.S. dollars) | As published | Adjustment | Revised | |||
A&T | ||||||
P&ARP | ||||||
AS&I | ||||||
H&C (1) | ( | ( | ||||
Segment Adjusted EBITDA | ||||||
Metal price lag | ( | |||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Aerospace rolled products | ||||||
Transportation, industry, defense and other rolled products | ||||||
Packaging rolled products | ||||||
Automotive rolled products | ||||||
Specialty and other thin-rolled products | ||||||
Automotive extruded products | ||||||
Other extruded products | ||||||
Other | ||||||
Total revenue | ||||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
United States | ||||||
Germany | ||||||
France | ||||||
Spain | ||||||
United Kingdom | ||||||
Poland | ||||||
Czech Republic | ||||||
All other | ||||||
Total revenue | ||||||
2025 | 2024 | 2023 | |||||||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | |||
Segment revenue | |||||||||||||||
Inter-segment elimination | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||||||
External revenue | |||||||||||||||
Cost of metal | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||||
Production costs | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||
Other segment expenses (A) | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||
Segment Adjusted EBITDA | ( | ( | ( | ||||||||||||
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
A&T | ||||||||
P&ARP | ||||||||
AS&I | ||||||||
H&C (A) | ( | ( | ( | |||||
Segment Adjusted EBITDA | ||||||||
Metal price lag (B) | ( | |||||||
Depreciation and amortization | 11, 13 | ( | ( | ( | ||||
Impairment of assets (C) | 5 | ( | ( | ( | ||||
Share based compensation | 21 | ( | ( | ( | ||||
Pension and other post-employment benefits - non - operating gains | 5, 17 | |||||||
Restructuring costs (D) | 5 | ( | ( | |||||
Unrealized gains / (losses) on derivatives | 5 | ( | ( | |||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 5 | ( | ||||||
Gains / (losses) on disposal (E) | 5 | ( | ( | |||||
Other (F) | ( | ( | ||||||
Expenses on factoring arrangements | 9 | ( | ( | ( | ||||
Finance costs – net | 6 | ( | ( | ( | ||||
Income before tax | ||||||||
Income tax expense | 7 | ( | ( | ( | ||||
Net income | ||||||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
A&T | ( | ( | ( | |||
P&ARP | ( | ( | ( | |||
AS&I | ( | ( | ( | |||
H&C (A) | ( | ( | ( | |||
Total capital expenditures (B) | ( | ( | ( | |||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
A&T | ( | ( | ( | |||
P&ARP | ( | ( | ( | |||
AS&I | ( | ( | ( | |||
H&C (A) | ( | ( | ( | |||
Total depreciation, amortization and impairment expense | ( | ( | ( | |||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
A&T | ||||
P&ARP | ||||
AS&I | ||||
H&C (A) | ||||
Deferred income tax assets | ||||
Cash and cash equivalents | ||||
Fair value of derivatives instruments and other financial assets | ||||
Total assets | ||||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
United States | ||||
France | ||||
Germany | ||||
Czech Republic | ||||
Other | ||||
Total property plant and equipment | ||||
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
Operating income and expenses | ||||||||
Realized gains / (losses) on derivatives (A) | 16 | ( | ||||||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net (A) | 16 | ( | ( | |||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ( | |||||||
Impairment of assets (B) | ( | ( | ( | |||||
Restructuring costs (C) | ( | ( | ||||||
Gains / (losses) on disposal (D) | ( | ( | ||||||
Result from the flood in Valais (E) | ||||||||
Non-operating income and expenses | ||||||||
Expenses on factoring arrangements | 9 | ( | ( | ( | ||||
Pension and other post-employment benefits | 17 | |||||||
Other (F) | ||||||||
Total other gains and losses - net | ( | ( | ||||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Interest expense on borrowings (A) | ( | ( | ( | |||
Interest expense on finance leases | ( | ( | ( | |||
Interest cost on pension and other long-term benefits | ( | ( | ( | |||
Net loss on settlement of debt (B) | ( | |||||
Realized and unrealized (losses) / gains on debt derivatives at fair value (C) | ( | |||||
Realized and unrealized exchange gains / (losses) on financing activities - net (C) | ( | ( | ||||
Other finance expenses | ( | ( | ( | |||
Capitalized borrowing costs (D) | ||||||
Finance expenses | ( | ( | ( | |||
Finance costs - net | ( | ( | ( | |||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Domestic (France) | ||||||
Foreign | ( | |||||
Income before tax | ||||||
Year ended December 31, | |||||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | ||||||
Income before tax | |||||||||
Income tax expense calculated at statutory tax rate | ( | ( | ( | ( | ( | ( | |||
United States | |||||||||
Base Erosion Anti-Abuse Tax | ( | ( | ( | ( | ( | ( | |||
Change in State Effective Tax Rate | ( | ( | |||||||
Share-based compensation | |||||||||
State and local income tax, net of federal income tax effect | ( | ( | ( | ( | ( | ( | |||
Statutory tax rate difference between France and the United States | |||||||||
Germany | |||||||||
Valuation Allowances | ( | ( | |||||||
Statutory tax rate difference between France and Germany | ( | ( | ( | ( | |||||
Cantonal and local income tax, net of federal income tax effect | |||||||||
Switzerland | |||||||||
Valuation Allowances | ( | ( | ( | ( | ( | ( | |||
Statutory tax rate difference between France and Switzerland | ( | ( | |||||||
Cantonal and local income tax, net of federal income tax effect | ( | ( | |||||||
Prior year adjustments | ( | ( | |||||||
Slovakia | |||||||||
Valuation Allowances | ( | ( | |||||||
Other | |||||||||
Valuation Allowances | ( | ( | ( | ( | |||||
Statutory tax rate difference between France and other jurisdictions | |||||||||
Enactment of new tax laws and rates | ( | ( | |||||||
Tax credits | |||||||||
Valuation Allowances | |||||||||
Nontaxable or nondeductible items | |||||||||
Share-based compensation | ( | ( | ( | ( | ( | ( | |||
Unrecognized Tax Benefits | |||||||||
Investment in Subsidiaries (A) | |||||||||
Tax audits | ( | ( | ( | ( | |||||
Value-added business tax (France only) | ( | ( | ( | ( | ( | ( | |||
Other | ( | ( | ( | ( | ( | ( | |||
Income tax expense at effective income tax rate | ( | ( | ( | ( | ( | ( | |||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Domestic (France) | ( | ( | ( | |||
Foreign | ( | ( | ( | |||
Current tax expense | ( | ( | ( | |||
Domestic (France) | ( | ( | ||||
Foreign | ( | ( | ( | |||
Deferred tax (expense) / benefit | ( | ( | ( | |||
Income tax expense | ( | ( | ( | |||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Unrecognized tax benefits at January 1, (A) | ||||||
Additions for tax position of the current year | ||||||
Additions for tax position of prior years | ||||||
Reductions for tax positions of prior years (B) | ( | |||||
Settlements with tax authorities | ( | ( | ||||
Reductions for expiration of statute of limitations | ( | ( | ||||
Translation effect | ||||||
Unrecognized tax benefits at December 31, (A) | ||||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
France | ( | ( | ( | |||
United States of America | ( | ( | ( | |||
Czech Republic | ( | ( | ( | |||
Switzerland | ( | ( | ( | |||
Canada | ( | ( | ||||
China | ( | ( | ||||
Germany | ( | |||||
Other | ( | |||||
Income Tax Paid at December 31, | ( | ( | ( | |||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Net deferred income tax assets | ||||
Net deferred income tax liabilities | ( | ( | ||
Net deferred taxes | ||||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Deferred income tax assets | ||||
Tax losses carried forward | ||||
Long term assets | ||||
Pensions | ||||
Derivative valuation | ||||
Interest carried forward | ||||
Other (A) | ||||
Total deferred income tax assets | ||||
Less: valuation allowance | ( | ( | ||
Deferred income tax assets, net of valuation allowance | ||||
Deferred income tax liabilities | ||||
Long-term assets | ( | ( | ||
Inventories | ( | ( | ||
Derivatives | ( | |||
Other | ( | |||
Deferred income tax liabilities | ( | ( | ||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
At January 1, | ||||||
Reduction | ( | ( | ( | |||
Addition | ||||||
At December 31, | ||||||
At December 31, 2025 | ||||||||
(in millions of U.S. dollars) | Tax Losses Carried Forward | Valuation Allowance | Carryforward Period | Earliest Year of Expiration | ||||
Net operating loss | ||||||||
United States | Indefinite | |||||||
United States | 20 years | 2032 | ||||||
France | ( | Indefinite | ||||||
Mexico | ( | 10 years | 2027 | |||||
Germany | ( | Indefinite | ||||||
Switzerland | ( | 7 years | 2028 | |||||
Other | ( | > 5 years or indefinite | ||||||
Total | ( | |||||||
Year ended December 31, | ||||||
(in millions of U.S. Dollars except share and per share amounts ) | 2025 | 2024 | 2023 | |||
Numerator: | ||||||
Net income attributable to equity holders of Constellium | ||||||
Denominator: | ||||||
Basic - weighted-average ordinary shares outstanding | ||||||
Dilutive effect of non-vested restricted stock units and performance- based restricted stock units | ||||||
Diluted - weighted-average ordinary shares, of restricted stock units and performance-based restricted stock units | ||||||
Basic earnings per share | $ | $ | $ | |||
Diluted earnings per share | $ | $ | $ | |||
At December 31, | ||||
2025 | 2024 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade receivables - gross | ||||
Allowance for credit losses | ( | ( | ||
Total trade receivables - net | ||||
Total other receivables | ||||
Total trade receivables and other | ||||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Finished goods | ||||
Work in progress | ||||
Raw materials | ||||
Stores and supplies | ||||
Total inventories | ||||
(in millions of U.S. dollars) | Land and Property Rights | Buildings | Machinery and Equipment | Construction Work in Progress | Other | Property, Plant and Equipment | ||||||
At December 31, 2025 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated depreciation | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2025 | ||||||||||||
At December 31, 2024 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated depreciation | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2024 |
At December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Depreciation expense related to property, plant and equipment | ( | ( | ( | |||
At December 31, | ||||||
(in millions of U.S. dollars) | Consolidated Balance Sheets | 2025 | 2024 | |||
Assets | ||||||
Operating lease right-of-use assets | Property, plant and equipment | |||||
Finance lease assets (A) | Property, plant and equipment | |||||
Total lease assets | ||||||
Liabilities | ||||||
Current: | ||||||
Operating lease liabilities | Trade payables and other | |||||
Finance lease liabilities | Short-term debt | |||||
Non-current: | ||||||
Operating lease liabilities | Trade payables and other | |||||
Finance lease liabilities | Long-term debt | |||||
Total lease liabilities | ||||||
At December 31, | ||||||||
(in millions of U.S. dollars) | Consolidated Income Statement | 2025 | 2024 | 2023 | ||||
Operating lease costs (A) | Cost of sales (excluding depreciation and amortization) | ( | ( | ( | ||||
Selling and administrative expenses | ( | ( | ( | |||||
Depreciation related to finance lease | Depreciation and amortization | ( | ( | ( | ||||
At December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Financing cash flows from finance leases | ( | ( | ( | |||
Operating cash flows from operating leases | ( | ( | ( | |||
At December 31, | ||||
2025 | 2024 | |||
Weighted-average remaining lease term | ||||
Operating leases | ||||
Finance leases | ||||
Weighted-average discount rate | ||||
Operating leases | ||||
Finance leases | ||||
At December 31, 2025 | ||||
(in millions of U.S. dollars) | Operating Leases | Finance Leases | ||
Years ending | ||||
2026 | ||||
2027 | ||||
2028 | ||||
2029 | ||||
2030 | ||||
Thereafter | ||||
Total non-cancelable minimum lease payments | ||||
Less: interest | ( | ( | ||
Present value of lease liabilities | ||||
(in millions of U.S. dollars) | Technology | Computer Software | Customer relationships | Work in Progress | Other | Total Intangible Assets | ||||||
At December 31, 2025 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated amortization | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2025 | ||||||||||||
At December 31, 2024 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated amortization | ( | ( | ( | ( | ( | |||||||
Net balance, at December 31, 2024 | ||||||||||||
At December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Amortization expense related to intangible assets | ( | ( | ( | |||
(in millions of U.S. Dollars) | At December 31, 2025 | |
Year ending | ||
2026 | ||
2027 | ||
2028 | ||
2029 | ||
2030 |
At December 31, | ||||
2025 | 2024 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade payables | ||||
Employees' entitlements | ||||
Other payables | ||||
Total other | ||||
Total trade payables and other | ||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Contract liabilities and other liabilities to customers at January 1, | ||||||
Revenue deferred to contract liabilities | ||||||
Revenue recognized from contract liabilities | ( | ( | ( | |||
Effect of changes in foreign currency rates and other changes | ( | ( | ||||
Contract liabilities and other liabilities to customers at December 31, | ||||||
At December 31, | ||||||||||
2025 | 2024 | |||||||||
(in millions of U.S. dollars) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) | $ | Floating | ||||||||
Senior Unsecured Notes | ||||||||||
Issued June 2020 and due 2028 | $ | ( | ||||||||
Issued February 2021 and due 2029 | $ | ( | ||||||||
Issued June 2021 and due 2029 | € | ( | ||||||||
Issued August 2024 and due 2032 | $ | ( | ||||||||
Issued August 2024 and due 2032 | € | ( | ||||||||
Finance lease liabilities | ||||||||||
Other loans | ||||||||||
Total debt | ( | |||||||||
Of which non-current | ||||||||||
Of which current (A) | ||||||||||
(in millions of U.S. dollars) | At December 31, 2025 | |
Year ending | ||
2026 | ||
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total undiscounted cash flows |
At December 31, | ||||||||||||
2025 | 2024 | |||||||||||
(in millions of U.S. dollars) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Currency net debt derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - assets | ||||||||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - liabilities | ||||||||||||
At December 31, | ||||||||||||||||
2025 | 2024 | |||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivatives instruments - assets | ||||||||||||||||
Fair value of derivatives instruments - liabilities | ||||||||||||||||
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2026-2031 | |||||
CHF | 2026-2029 | |||||
CZK | 2026 | |||||
Other currencies | 2026-2027 |
Purchased currencies | ||||||
USD | 2026-2027 | |||||
CHF | 2026-2028 | |||||
CZK | 2026-2027 | |||||
Other currencies | 2026 |
Year ended December 31, | ||||||||
(in millions of U.S. dollars) | Notes | 2025 | 2024 | 2023 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized gains / (losses) on foreign currency derivatives - net (A) | 5 | ( | ||||||
Unrealized gains / (losses) on foreign currency derivatives - net (B) | 5 | ( | ( | |||||
Derivatives that qualify for hedge accounting | ||||||||
Included in Other comprehensive income | ||||||||
Unrealized gains / (losses) on foreign currency derivatives - net | ( | |||||||
(Losses) / gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | ( | |||||||
Included in Revenue (C) | ||||||||
Realized losses on foreign currency derivatives - net (A) | 5 | ( | ( | ( | ||||
Unrealized gains / (losses) on foreign currency derivatives - net | 5 | ( | ||||||
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Derivatives that do not qualify for hedge accounting | ||||||
Included in Finance costs - net | ||||||
Realized (losses) / gains on foreign currency derivatives - net (A) | ( | |||||
Unrealized gains / (losses) on foreign currency derivatives - net | ( | |||||
Total | ( | |||||
(in millions of U.S. dollars) | Maturity Year | Less than 1 year | Over 1 year | |||
Metal | 2026-2028 | |||||
Natural gas | 2026-2028 |
Year ended December 31, | ||||||
(in millions of U.S. dollars) | 2025 | 2024 | 2023 | |||
Derivatives that do not qualify for hedge accounting | ||||||
Included in Other gains and losses - net | ||||||
Realized gains / (losses) on commodities derivatives - net (A) | ( | |||||
Unrealized gains on commodities derivatives - net | ||||||
At December 31, | ||||||||||||
2025 | 2024 | 2023 | ||||||||||
Rate of increase in salaries | Discount rate | Expected return rate (A) | Rate of increase in salaries | Discount rate | Expected return rate (A) | Rate of increase in salaries | Discount rate | Expected return rate (A) | ||||
Pension | ||||||||||||
OPEB | n/a | n/a | n/a | |||||||||
At December 31, | |||||||
2025 | 2024 | ||||||
(in millions of U.S. dollars) | Pension Benefits | OPEB and Other Benefits | Total | Pension Benefits | OPEB and Other Benefits | Total | |
Present value of funded obligation | |||||||
Fair value of plan assets | ( | ( | ( | ( | |||
Deficit of funded plans | |||||||
Present value of unfunded obligation | |||||||
Net liability arising from defined benefit obligation | |||||||
of which non-current | |||||||
of which current | |||||||
Year ended December 31, | ||||||||
2025 | 2024 | 2023 | ||||||
(in millions of U.S. dollars) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | ||
Current service cost | ( | ( | ( | ( | ( | ( | ||
Interest cost | ( | ( | ( | ( | ( | ( | ||
Expected return on plan assets | ||||||||
Immediate recognition of gains arising over the year | ( | ( | ||||||
Amortization of past service gain | ||||||||
Amortization of net actuarial gain | ( | |||||||
Curtailment and settlements | ||||||||
Total net pension and other long-term benefit cost | ( | ( | ( | ( | ||||
Year ended December 31, 2025 | ||||||||||
Defined benefit obligations | Plan assets | Net defined benefit liability | ||||||||
(in millions of U.S. dollars) | Pension benefits | OPEB and Other Benefits | Total | |||||||
At January 1, 2025 | ( | |||||||||
Included in the Consolidated Income Statement | ||||||||||
Current service cost | — | |||||||||
Interest cost / (income) | ( | |||||||||
Immediate recognition of gains arising over the year | — | |||||||||
Included in the Statement of Comprehensive Income | ||||||||||
Remeasurements due to: | ||||||||||
—actual return less interest on plan assets | — | — | — | ( | ( | |||||
—changes in financial assumptions | ( | ( | — | ( | ||||||
—changes in demographic assumptions | ( | ( | — | ( | ||||||
—experience (gains)/ losses | ( | ( | ( | — | ( | |||||
Past service cost | — | |||||||||
Effects of changes in foreign exchange rates | ( | |||||||||
Included in the Consolidated Statement of Cash Flows | ||||||||||
Benefits paid | ( | ( | ( | ( | ||||||
Settlement | ( | ( | ||||||||
Contributions by the Group | — | — | — | ( | ( | |||||
Contributions by the plan participants | ( | |||||||||
At December 31, 2025 | ( | |||||||||
Year ended December 31, 2024 | ||||||||||
Defined benefit obligations | Plan Assets | Net defined benefit liability | ||||||||
(in millions of U.S. dollars) | Pension benefits | OPEB and Other Benefits | Total | |||||||
At January 1, 2024 | ( | |||||||||
Included in the Consolidated Income Statement | ||||||||||
Current service cost | — | |||||||||
Interest cost / (income) | ( | |||||||||
Immediate recognition of gains arising over the year | — | |||||||||
Included in the Statement of Comprehensive Income | ||||||||||
Remeasurements due to: | ||||||||||
—actual return less interest on plan assets | — | — | — | ( | ( | |||||
—changes in financial assumptions | ( | ( | ( | — | ( | |||||
—changes in demographic assumptions | — | |||||||||
—experience (gains)/ losses | ( | — | ||||||||
Effects of changes in foreign exchange rates | ( | ( | ( | ( | ||||||
Included in the Consolidated Statement of Cash Flows | ||||||||||
Benefits paid | ( | ( | ( | ( | ||||||
Contributions by the Group | — | — | — | ( | ( | |||||
Contributions by the plan participants | ( | |||||||||
At December 31, 2024 | ( | |||||||||
At December 31, | ||||
(in millions of U.S. dollars) | 2025 | 2024 | ||
Cash & cash equivalents | ||||
Equities | ||||
Fixed income | ||||
Property | ||||
Other | ||||
Total fair value of plan assets | ||||
Estimated benefits payments | ||||
(in millions of U.S. dollars) | Pensions | OPEB and Other Benefits | ||
Year ended December 31, | ||||
2026 | ||||
2027 | ||||
2028 | ||||
2029 | ||||
2030 | ||||
2031 to 2035 | ||||
At December 31, | ||||||||
2025 | 2024 | |||||||
(in millions of U.S. dollars) | Current | Non-current | Current | Non-current | ||||
Close down and environmental remediation costs | ||||||||
Restructuring costs | ||||||||
Legal claims and other costs | ||||||||
Total provisions | ||||||||
At December 31, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2025 | ( | ( | ( | |||||
Other comprehensive income / (loss) before reclassification | ||||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ( | ( | ||||||
At December 31, 2025 | ( | |||||||
At December 31, 2024 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2024 | ( | ( | ||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | |||||||
At December 31, 2024 | ( | ( | ( | |||||
At December 31, 2023 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2023 | ( | ( | ||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ( | ( | ( | |||||
At December 31, 2023 | ( | ( | ||||||
2025 PSUs | 2024 PSUs | |||
Fair value at grant date (in dollars) | ||||
Share price at grant date (in dollars) | ||||
Dividend yield | ||||
Expected volatility (A) | ||||
Risk-free interest rate (US government bond yield) | ||||
Model used | Monte Carlo | Monte Carlo |
Performance-Based RSU | Restricted Stock Units | ||||||||
Potential Shares | Weighted-Average Grant-Date Fair Value per Share | Potential Shares | Weighted-Average Grant-Date Fair Value per Share | ||||||
At January 1, 2025 | $ | $ | |||||||
Granted (A) | $ | $ | |||||||
Over-performance (B) | $ | $ | |||||||
Vested | ( | $ | ( | $ | |||||
Forfeited (C) | ( | $ | ( | $ | |||||
At December 31, 2025 | $ | $ | |||||||
Plan Category | (a) Number of securities to be issued upon exercise of outstanding options, warrants and rights | (b) Weighted average exercise price of outstanding options, warrants and rights | (c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column a) | |||
Equity compensation plans approved by shareholders (1) | 2,794,799 (2) | N/A | 5,531,615 (3) | |||
Equity compensation plans not approved by shareholders (1) | 1,451,353 (4) | N/A | N/A | |||
Total | 4,246,152 | N/A | 5,531,615 |
3.1 | |
4.1 | |
4.2 | |
4.3 | |
4.4 | |
4.5 | |
4.6 | |
4.7 | |
4.8 | |
4.9 | |
10.1 | |
10.2 | |
10.3 | |
10.4 | |
10.5 | |
10.6 | |
10.7 | |
10.8 | |
10.9 | |
10.10 | |
10.11 | |
10.12 | |
10.13 | |
10.14 | |
10.15 | |
10.16 | |
10.17 | |
10.18 | |
10.19 | |
10.20 | |
10.21 | |
10.66 | |
10.67 | |
10.68 | |
10.69 | |
10.70 | |
10.71 | |
10.72 | |
10.73 | |
10.74 | |
10.75 | |
10.76 | |
10.77 | |
10.78 | |
10.79 | |
10.80 | |
10.81 | |
10.82 | |
10.83 | |
10.84 | |
10.85 | |
10.86 | |
10.87 | |
10.88 | |
10.89 | |
10.90 | |
19.1 | |
21.1 | |
23.1 | |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
97.1 | |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104. | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | ||
Date: February 25, 2026 | By | /s/ Ingrid Joerg |
Ingrid Joerg | ||
Chief Executive Officer and Director | ||
Name | Capacity | Date | ||
/s/ Ingrid Joerg | Chief Executive Officer and Director | February 25, 2026 | ||
Ingrid Joerg | (Principal Executive Officer) | |||
/s/ Jack Guo | Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | February 25, 2026 | ||
Jack Guo | ||||
/s/ Jean-Christophe Deslarzes | Chairman | February 25, 2026 | ||
Jean-Christophe Deslarzes | ||||
/s/ Michiel Brandjes | Director | February 25, 2026 | ||
Michiel Brandjes | ||||
/s/ John Ormerod | Director | February 25, 2026 | ||
John Ormerod | ||||
/s/ Lori A. Walker | Director | February 25, 2026 | ||
Lori A. Walker | ||||
/s/ Martha Brooks | Director | February 25, 2026 | ||
Martha Brooks | ||||
/s/ Isabelle Boccon-Gibod | Director | February 25, 2026 | ||
Isabelle Boccon-Gibod | ||||
/s/ Jean-Philippe Puig | Director | February 25, 2026 | ||
Jean-Philippe Puig | ||||
/s/ Jean-François Verdier | Employee Director | February 25, 2026 | ||
Jean-François Verdier | ||||
/s/ Wiebke Weiler | Employee Director | February 25, 2026 | ||
Wiebke Weiler | ||||
/s/ Emmanuel Blot | Director | February 25, 2026 | ||
Emmanuel Blot | ||||
/s/ Bradley Soultz | Director | February 25, 2026 | ||
Bradley Soultz |